☆ 4.5 Article

Design, synthesis and biological evaluation of quinazoline SOS1 inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Oncology

GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists

S. V. S. Deo et al.

Summary: Cancer is becoming a major global public health challenge, with the burden of cancer increasing globally according to the GLOBOCAN 2020 report which estimates the occurrence of 36 cancers in 185 countries. There are global disparities in cancer incidence and mortality in different geographic regions, and the human development index (HDI) also affects cancer incidence and projected global burden. Surgical oncologists play a crucial role in future global cancer control strategies.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition

Marco H. Hofmann et al.

Summary: Inhibiting SOS1, a KRAS activator and important feedback node, is an effective approach to treat KRAS-driven cancers. The highly potent and selective small-molecule SOS1 inhibitor, BI-3406, reduces cellular proliferation of KRAS-driven cancers by preventing the interaction with KRAS. Combination of SOS1 and MEK inhibition represents a novel and effective therapeutic concept for addressing KRAS-driven tumors.

CANCER DISCOVERY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Targeting the untargetable KRAS in cancer therapy

Pingyu Liu et al.

ACTA PHARMACEUTICA SINICA B (2019)

Add to Collection

Article Multidisciplinary Sciences

Drugging an undruggable pocket on KRAS

Dirk Kessler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Article Chemistry, Medicinal

Novel Methyl-aza-quinazolines as Inhibitors of the RAS-SOS Interaction

Gerard Rosse

ACS Medicinal Chemistry Letters (2019)

Add to Collection

Meeting Abstract Oncology

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction

Benjamin Bader

MOLECULAR CANCER THERAPEUTICS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis

Pilar Liceras-Boillos et al.

MOLECULAR AND CELLULAR BIOLOGY (2018)

Add to Collection

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Ras activation revisited: role of GEF and GAP systems

Anne Hennig et al.

BIOLOGICAL CHEMISTRY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Combined Rational Design and a High Throughput Screening Platform for Identifying Chemical Inhibitors of a Ras-activating Enzyme

Chris R. Evelyn et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Rational Design of Small Molecule Inhibitors Targeting the Ras GEF, SOS1

Chris R. Evelyn et al.

CHEMISTRY & BIOLOGY (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Small-molecule modulation of Ras signaling

Jochen Spiegel et al.

NATURE CHEMICAL BIOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

Jonathan M. Ostrem et al.

NATURE (2013)

Add to Collection

Article Cell Biology

Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway

C. Lv et al.

CELL DEATH & DISEASE (2013)

Add to Collection

Article Chemistry, Multidisciplinary

Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation

Qi Sun et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)

Add to Collection

Review Oncology

Human Cancer Classification: A Systems Biology-Based Model Integrating Morphology, Cancer Stem Cells, Proteomics, and Genomics

Halliday A. Idikio

JOURNAL OF CANCER (2011)

Add to Collection

Review Biotechnology & Applied Microbiology

Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets

Panagiotis A. Konstantinopoulos et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.